Senores Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Georgia, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2877 Pearl Ridge Trce, Buford, Georgia, ...Phone Number
(706) 684-0388Website
www.senorespharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Senores Pharmaceuticals
Senores Pharmaceuticals specializes in the manufacturing and development of affordable, high-quality complex generics that are certified by global food and drug authorities. The company is committed to global wellness, ensuring that their cost-effective products meet the medical needs of patients who often rely on out-of-pocket expenditures. With a presence in 49 countries, Senores Pharmaceuticals adheres to stringent quality standards and WHO cGMP guidelines, making their products accessible worldwide. They operate multiple manufacturing facilities, including USFDA approved plants, and serve over 300 customers globally.Explore more
Senores Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Senores Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Senores Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Senores Pharmaceuticals had a recent Job posting/layoffs
Check out if Senores Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Senores Pharmaceuticals
Check if Senores Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Senores Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Senores Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Senores Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Senores Pharmaceuticals as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Senores Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Senores Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Senores Pharmaceuticals.
Senores Pharmaceuticals Tech Stack
A closer look at the technologies used by Senores Pharmaceuticals
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Person-Based
Senores Pharmaceuticals News & Media
Senores Pharmaceuticals to increase stake in Havix - Indian Pharma Post
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulationsDr. Reddy’s, Senores Pharmaceuticals launch generic Stromectol
Generic Stromectol is an antiparasitic medicine used to treat certain infections.Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #DrReddys--Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg in the U.S. market.Senores Pharmaceuticals, Inc. announces the launch of Nicardipine Hydrochloride Capsules USP, 20 mg and 30 mg in the U.S. market
ATLANTA, Sept. 25, 2023 /PRNewswire/ -- Senores Pharmaceuticals, Inc. announced the launch of Nicardipine Hydrochloride Capsules USP, 20 mg and 30 mg, a bioequivalent and therapeutically equivalent to Cardene Capsules, 20 mg and 30 mg, of Chiesi USA, Inc. in the U.S. market. The product...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Senores Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Senores Pharmaceuticals specializes in the manufacturing and development of affordable, high-quality complex generics that are certified by global food and drug authorities. The company is committed to global wellness, ensuring that their cost-effective products meet the medical needs of patients who often rely on out-of-pocket expenditures. With a... Read More
